Brian A. Kahan, Esquire, on behalf of Lato Drug Company Inc. d/b/a Post Haste Pharmacy and Robert Fishman, RPh.; The Petitioners seek a Declaratory Statement from the Board with regard to section 465.185(1), F.S. and Rule 64B16-27.700, Florida ...

 

DEPARTMENT OF HEALTH

Board of Pharmacy

RULE NO.:RULE TITLE:

64B16-27.700Definition of Compounding

NOTICE IS HEREBY GIVEN that Board of Pharmacy has received the petition for declaratory statement from Brian A. Kahan, Esquire, on behalf of Lato Drug Company Inc. d/b/a Post Haste Pharmacy and Robert Fishman, RPh. The petition seeks the agency’s opinion as to the applicability of Section 465.185(1), F.S. and Rule 64B16-27.700, F.A.C., as they apply to the petitioner.

The Petitioners seek a Declaratory Statement from the Board with regard to Section 465.185(1), F.S., and Rule 64B16-27.700, Florida Administrative Code, that the petitioners’ contemplated business arrangement for compounding medications for veterinary use, as outlined in the petition, would not subject Petitioners to discipline under the cited statute and rule. Except for good cause shown, motions for leave to intervene must be filed within 21 days after the publication of this notice.

A copy of the Petition for Declaratory Statement may be obtained by contacting: Allison Dudley, Executive Director, Board of Pharmacy, 4052 Bald Cypress Way, Bin #C04, Tallahassee, Florida 32399-3254 or by email: [e-mail].